Altimmune, Inc.ALTNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR+45.0%
5Y CAGR-9.3%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+45.0%/yr
vs -7.8%/yr prior
5Y CAGR
-9.3%/yr
Recent acceleration
Acceleration
+52.8pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 34.02% |
| 2024 | 15.60% |
| 2023 | 5.85% |
| 2022 | 11.17% |
| 2021 | 16.68% |
| 2020 | 55.39% |
| 2019 | -12.95% |
| 2018 | 15.47% |
| 2017 | -26.55% |
| 2016 | 85.06% |